The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy

The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy

Obstructive sleep apnoea syndrome (OSAS) is an under-recognized medical disease. The main risk factors for OSAS are male sex, older age, obesity, and metabolic syndrome, that are also associated with male hypogonadism (MH). Therefore, obesity has been classically identified as the most evident link...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Andrea Graziani, Giuseppe Grande, Alberto Ferlin
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	Frontiers Media S.A. 2023-10-01
Reeks:	Frontiers in Reproductive Health
Onderwerpen:	OSAS hypogonadism testosterone testosterone replacement therapy obesity
Online toegang:	https://www.frontiersin.org/articles/10.3389/frph.2023.1219239/full

Gelijkaardige items

Management of Male Fertility in Hypogonadal Patients on Testosterone Replacement Therapy
door: Julius Fink, et al.
Gepubliceerd in: (2024-02-01)

Clinical and pharmacological basis of the use of testosterone drugs for hormonal replacement therapy for hypogonadism in men
door: N. I. Volkova, et al.
Gepubliceerd in: (2022-09-01)

Usefulness of routine assessment of free testosterone for the diagnosis of functional male hypogonadism
door: Paolo Facondo, et al.
Gepubliceerd in: (2022-12-01)

ASSESSING CARDIOVASCULAR SAFETY OF TESTOSTERONE REPLACEMENT THERAPY FOR MALE HYPOGONADISM: A SYSTEMATIC REVIEW AND META-ANALYSIS
door: Manarul Iman Alfafa Rachman, et al.
Gepubliceerd in: (2024-09-01)

Impact of testosterone levels and testosterone replacement ther-apy on men’s health
door: Zuzanna Karbowska, et al.
Gepubliceerd in: (2023-12-01)

Acquired Male Hypogonadism in the Post-Genomic Era—A Narrative Review
door: Giuseppe Grande, et al.
Gepubliceerd in: (2023-09-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Gepubliceerd in: (2012-12-01)

Plasma metabolomics in male primary and functional hypogonadism
door: Giuseppe Grande, et al.
Gepubliceerd in: (2023-05-01)

Age-Related Male Hypogonadism and Cognitive Impairment in the Elderly: Focus on the Effects of Testosterone Replacement Therapy on Cognition
door: Giuseppe Lisco, et al.
Gepubliceerd in: (2020-10-01)

LATE ONSET HYPOGONADISM: TO TREAT, NOT TO TREAT AND WHO MUST TREAT?
door: Z. R. Gusova, et al.
Gepubliceerd in: (2016-03-01)

Testosterone replacement therapy and vascular thromboembolic events: a systematic review and meta-analysis
door: Rossella Cannarella, et al.
Gepubliceerd in: (2024-01-01)

Sleep disorders and testosterone deficiency in men
door: I. A. Khripun, et al.
Gepubliceerd in: (2025-01-01)

Evaluation of sexual functional status and consistency of scales in patients with hypogonadotropic hypogonadism before and after testosterone replacement therapy: a single-center experience
door: Umit Aydogan, et al.
Gepubliceerd in: (2023-01-01)

Application of Transdermal Testosterone in Treatment of Male Hypogonadism
door: Mahgol Tajbakhsh, et al.
Gepubliceerd in: (2018-10-01)

The association of hypogonadism with depression and its treatments
door: Rita Indirli, et al.
Gepubliceerd in: (2023-08-01)

Testosterone Replacement Therapy: Effects on Blood Pressure in Hypogonadal Men
door: Geoffrey Hackett, et al.
Gepubliceerd in: (2024-10-01)

Guidelines for the Diagnosis and Treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus
door: Ivan I. Dedov, et al.
Gepubliceerd in: (2017-12-01)

Novel perspectives of testosterone therapy in men with functional hypogonadism: traversing the gaps of knowledge
door: Kristina Groti Antonič, et al.
Gepubliceerd in: (2024-12-01)

The HEAT-Registry (HEmatopoietic Affection by Testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men
door: Michael Zitzmann, et al.
Gepubliceerd in: (2022-12-01)

Testosterone replacement therapy in adolescents and young men
door: Alexandra Aponte Varnum, et al.
Gepubliceerd in: (2024-10-01)

Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism
door: Maurício de Almeida Ferreira, et al.
Gepubliceerd in: (2022-02-01)

A National Analysis of Temporal Changes in Prescribing of Testosterone Replacement Therapy Considering Methods of Delivery and Government Regulation
door: Andrew Morton, et al.
Gepubliceerd in: (2021-01-01)

Safety Aspects and Rational Use of Testosterone Undecanoate in the Treatment of Testosterone Deficiency: Clinical Insights
door: Campbell K, et al.
Gepubliceerd in: (2023-03-01)

Syndrome of hypogonadism in males
Gepubliceerd in: (2014-06-01)

Racial differences in hypogonadal improvement and prostate-specific antigen levels in hypogonadal men treated with testosterone replacement therapy
door: Robert M. Coward, et al.
Gepubliceerd in: (2010-12-01)

Testosterone Replacement Therapy in Adolescents With Sickle Cell Disease Reverses Hypogonadism Without Promoting Priapism: A Case Report
door: Belinda F. Morrison, et al.
Gepubliceerd in: (2015-11-01)

Osteoporosis and bone metabolism in patients with Klinefelter syndrome
door: Giuseppe Grande, et al.
Gepubliceerd in: (2023-07-01)

Testosterone and aging male, a perspective from a developing country
door: Bac Nguyen Hoai, et al.
Gepubliceerd in: (2023-12-01)

Testosterone treatment in the aging male: myth or reality?
door: Nicole Nigro, et al.
Gepubliceerd in: (2012-03-01)

Does Testosterone Salvage PDE5i Non-Responders? A Scoping Review
door: Mike Pignanelli, et al.
Gepubliceerd in: (2023-02-01)

Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft)
door: Galina Afanas'evna Melnichenko, et al.
Gepubliceerd in: (2017-06-01)

Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality
door: Kevin M. Pantalone, et al.
Gepubliceerd in: (2019-03-01)

Secondary male hypogonadism: A prevalent but overlooked comorbidity of obesity
door: María Molina-Vega, et al.
Gepubliceerd in: (2018-01-01)

The role of anti-aging approaches in managing hypogonadism in sedentary older males
door: Khaled A. Abdel-Sater
Gepubliceerd in: (2024-11-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Gepubliceerd in: (2013-03-01)

High C-reactive protein is associated with increased risk of biochemical hypogonadism: a population-based cohort study
door: Amar Osmancevic, et al.
Gepubliceerd in: (2022-06-01)

Association of hypogonadism with the severity of chronic obstructive pulmonary disease
door: MA. Zohal, et al.
Gepubliceerd in: (2015-12-01)

The clinical and epidemiological characteristics of hypogonadism in men with type 2 diabetes mellitus
door: Galina A. Mel'nichenko, et al.
Gepubliceerd in: (2019-12-01)

The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
door: Galina A. Melnichenko, et al.
Gepubliceerd in: (2019-06-01)

Clomiphene citrate treatment for late onset hypogonadism: rise and fall
door: Marcelo Marconi, et al.